These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. No fumarate hydratase (FH) mutations in hereditary prostate cancer. Lehtonen R; Kiuru M; Rökman A; Ikonen T; Cunningham JM; Schaid DJ; Matikainen M; Nupponen NN; Karhu A; Kallioniemi OP; Thibodeau SN; Schleutker J; Aaltonen LA J Med Genet; 2003 Mar; 40(3):e19. PubMed ID: 12624148 [No Abstract] [Full Text] [Related]
44. [Genetics of prostate cancer]. Thomas F; Jaïs P; Cohen-Akenine A Bull Cancer; 2001 Mar; 88(3):287-94. PubMed ID: 11313206 [TBL] [Abstract][Full Text] [Related]
45. GeneLink: a database to facilitate genetic studies of complex traits. Gillanders EM; Masiello A; Gildea D; Umayam L; Duggal P; Jones MP; Klein AP; Freas-Lutz D; Ibay G; Trout K; Wolfsberg TG; Trent JM; Bailey-Wilson JE; Baxevanis AD BMC Genomics; 2004 Oct; 5():81. PubMed ID: 15491493 [TBL] [Abstract][Full Text] [Related]
46. A 6-Mb high-resolution physical and transcription map encompassing the hereditary prostate cancer 1 (HPC1) region. Carpten JD; Makalowska I; Robbins CM; Scott N; Sood R; Connors TD; Bonner TI; Smith JR; Faruque MU; Stephan DA; Pinkett H; Morgenbesser SD; Su K; Graham C; Gregory SG; Williams H; McDonald L; Baxevanis AD; Klingler KW; Landes GM; Trent JM Genomics; 2000 Feb; 64(1):1-14. PubMed ID: 10708513 [TBL] [Abstract][Full Text] [Related]
47. Inherited breast and ovarian cancer. What are the risks? What are the choices? King MC; Rowell S; Love SM JAMA; 1993 Apr; 269(15):1975-80. PubMed ID: 8464130 [No Abstract] [Full Text] [Related]
48. Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22. Cabeza-Arvelaiz Y; Sepulveda JL; Lebovitz RM; Thompson TC; Chinault AC Oncogene; 2001 Jul; 20(31):4169-79. PubMed ID: 11464283 [TBL] [Abstract][Full Text] [Related]
49. Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model. Hyytinen ER; Thalmann GN; Zhau HE; Karhu R; Kallioniemi OP; Chung LW; Visakorpi T Br J Cancer; 1997; 75(2):190-5. PubMed ID: 9010025 [TBL] [Abstract][Full Text] [Related]
50. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Cader MZ; Steckley JL; Dyment DA; McLachlan RS; Ebers GC Neurology; 2005 Jul; 65(1):156-8. PubMed ID: 16009908 [TBL] [Abstract][Full Text] [Related]
51. Re: prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. Hsieh CL; Oakley-Girvan I; Gallagher RP; Wu AH; Kolonel LN; Teh CZ; Halpern J; West DW; Paffenbarger RS; Whittemore AS J Natl Cancer Inst; 1997 Dec; 89(24):1893-4. PubMed ID: 9414179 [No Abstract] [Full Text] [Related]
52. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region. Baffoe-Bonnie AB; Smith JR; Stephan DA; Schleutker J; Carpten JD; Kainu T; Gillanders EM; Matikainen M; Teslovich TM; Tammela T; Sood R; Balshem AM; Scarborough SD; Xu J; Isaacs WB; Trent JM; Kallioniemi OP; Bailey-Wilson JE Hum Genet; 2005 Aug; 117(4):307-16. PubMed ID: 15906096 [TBL] [Abstract][Full Text] [Related]
53. No evidence of linkage for chromosome 1q42.2-43 in prostate cancer. Whittemore AS; Lin IG; Oakley-Girvan I; Gallagher RP; Halpern J; Kolonel LN; Wu AH; Hsieh CL Am J Hum Genet; 1999 Jul; 65(1):254-6. PubMed ID: 10364541 [No Abstract] [Full Text] [Related]
54. Genome analysis yields mutations linked to hereditary prostate cancer. Vastag B JAMA; 2002 Feb; 287(7):827-8. PubMed ID: 11851558 [No Abstract] [Full Text] [Related]
55. Prospects for genetic diagnosis of inherited predisposition to cancer. Ponder BA Trends Biotechnol; 1990 Apr; 8(4):98-104. PubMed ID: 1366530 [TBL] [Abstract][Full Text] [Related]
56. Homing in on prostate cancer gene. Pennisi E Science; 1996 Nov; 274(5291):1301. PubMed ID: 8966598 [No Abstract] [Full Text] [Related]
57. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Smith JR; Freije D; Carpten JD; Grönberg H; Xu J; Isaacs SD; Brownstein MJ; Bova GS; Guo H; Bujnovszky P; Nusskern DR; Damber JE; Bergh A; Emanuelsson M; Kallioniemi OP; Walker-Daniels J; Bailey-Wilson JE; Beaty TH; Meyers DA; Walsh PC; Collins FS; Trent JM; Isaacs WB Science; 1996 Nov; 274(5291):1371-4. PubMed ID: 8910276 [TBL] [Abstract][Full Text] [Related]
58. Familial prostate cancer studies in Utah. Neuhausen SL; Skolnick MH; Cannon-Albright L Br J Urol; 1997 Mar; 79 Suppl 1():15-20. PubMed ID: 9088268 [No Abstract] [Full Text] [Related]
59. Involvement of the RNAse L gene in prostate cancer. Kieffer N; Schmitz M; Scheiden R; Nathan M; Faber JC Bull Soc Sci Med Grand Duche Luxemb; 2006; (1):21-8. PubMed ID: 16869093 [TBL] [Abstract][Full Text] [Related]
60. Localization of a prostate cancer predisposition gene to an 880-kb region on chromosome 22q12.3 in Utah high-risk pedigrees. Camp NJ; Farnham JM; Cannon-Albright LA Cancer Res; 2006 Oct; 66(20):10205-12. PubMed ID: 17047086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]